|
|
|
Corporate Profile: Sunesis
Pharmaceuticals
| Summary: |
Founded in
June 1998, Sunesis Pharmaceuticals is committed to
becoming a leader in the discovery of important new
pharmaceutical products for the treatment of human
disease. They are doing this by applying a revolutionary
new approach to drug discovery that is based on a
novel chemical methodology combined with critical
insights into the nature of molecular recognition
between natural macromolecules and their substrates
or ligands. |
| Address (HQ):
|
395 Oyster Point Boulevard
Suite 400
South San Francisco, CA 94080 |
| Phone #'s (HQ): |
Main |
(650) 266-3500 |
| Human Resources |
not known |
| Investor Relations |
not known |
| Fax #'s (HQ): |
Main |
(650) 266-3505 |
| Human Resources |
(650) 266-3503 |
| Investor Relations |
not known |
| Financial
information: |
| SNSS |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
